First-Line Nivolumab Plus Ipilimumab in Recurrent/Metastatic Head and Neck Cancer-What Happened?Barbara BurtnessJOURNAL OF CLINICAL ONCOLOGY（2023）引用 0|浏览1暂无评分关键词nivolumab,neck cancer—what,recurrent/metastatic head,first-lineAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
